NPI: 1639783509 · DORAL, FL 33122 · General Acute Care Hospital · NPI assigned 09/08/2020
Authorized official KNIGHT, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | KNIGHT, MARK (EVP CFO) |
| Parent Organization | PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA |
| NPI Enumeration Date | 09/08/2020 |
Other providers sharing the same authorized official: KNIGHT, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 8,890 | $156K |
| 2022 | 38,165 | $994K |
| 2023 | 24,464 | $632K |
| 2024 | 16,253 | $199K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,996 | 4,313 | $489K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,134 | 4,330 | $462K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,348 | 2,071 | $257K |
| G0378 | Hospital observation service, per hour | 3,632 | 1,586 | $185K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 521 | 456 | $151K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 520 | 501 | $149K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 372 | 311 | $87K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 577 | 502 | $51K |
| 70450 | Computed tomography, head or brain; without contrast material | 783 | 572 | $49K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 59 | 57 | $17K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 75 | 63 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 595 | 500 | $16K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,420 | 1,184 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | 617 | 500 | $9K |
| 80053 | Comprehensive metabolic panel | 6,768 | 3,745 | $5K |
| 84484 | 4,236 | 1,568 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,294 | 5,739 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 640 | 252 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 190 | 161 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 251 | 213 | $2K |
| 97162 | 158 | 103 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 77 | 75 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 357 | 226 | $846.64 |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,543 | 1,620 | $760.62 |
| 71045 | Radiologic examination, chest; single view | 2,316 | 1,507 | $646.89 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,118 | 1,827 | $609.83 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,066 | 810 | $553.36 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 18 | 14 | $546.43 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,383 | 1,104 | $544.02 |
| 86850 | 543 | 439 | $535.47 | |
| 86803 | 804 | 689 | $531.24 | |
| 85610 | 1,957 | 1,368 | $505.75 | |
| 85730 | 1,696 | 1,253 | $485.23 | |
| 81001 | 4,027 | 2,892 | $477.38 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 694 | 570 | $446.38 |
| 86703 | 749 | 677 | $416.94 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 777 | 567 | $391.50 |
| 86900 | 592 | 488 | $381.94 | |
| 86901 | 592 | 488 | $381.94 | |
| 83735 | 2,062 | 825 | $324.27 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,486 | 1,039 | $315.17 |
| J3490 | Unclassified drugs | 569 | 325 | $315.17 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 108 | 67 | $246.93 |
| 71046 | Radiologic examination, chest; 2 views | 159 | 138 | $186.51 |
| 84703 | 1,454 | 1,241 | $166.01 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 612 | 487 | $142.57 |
| 83880 | 823 | 424 | $77.80 | |
| 83690 | 1,345 | 1,084 | $60.50 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 22 | 12 | $48.70 |
| 84100 | 318 | 218 | $36.00 | |
| 76801 | 66 | 55 | $32.64 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 198 | 190 | $21.37 |
| 80076 | 458 | 395 | $16.86 | |
| 83605 | 524 | 344 | $16.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 110 | 84 | $13.50 |
| 87186 | 232 | 182 | $13.00 | |
| 87040 | 379 | 179 | $8.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 45 | 43 | $7.50 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 15 | 13 | $4.55 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,541 | 1,155 | $3.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 634 | 367 | $3.31 |
| 86140 | 176 | 155 | $3.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 699 | 564 | $3.31 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 385 | 311 | $2.27 |
| J1644 | Injection, heparin sodium, per 1000 units | 418 | 122 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 31 | 24 | $0.00 |
| 84702 | 537 | 386 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 417 | 279 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 130 | 76 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 144 | 69 | $0.00 |
| 81025 | 52 | 52 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 287 | 118 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 81 | 76 | $0.00 |
| 73610 | 14 | 14 | $0.00 | |
| 85007 | 65 | 43 | $0.00 | |
| 85379 | 61 | 51 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 212 | 170 | $0.00 |
| 87077 | 232 | 185 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 345 | 121 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 95 | 84 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 313 | 212 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 66 | 40 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 68 | 34 | $0.00 |
| 82550 | 92 | 59 | $0.00 | |
| 97166 | 16 | 12 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 45 | 34 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 13 | 12 | $0.00 |
| 85652 | 31 | 26 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 34 | 26 | $0.00 |
| 88304 | 32 | 27 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 13 | 13 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 13 | 12 | $0.00 |